Thyroseq genomic classifier tests
Ended Awarded Last action
- Contract number
- 36C24625N0028
- Awardee
-
Cytopath Biopsy Lab Inc. UEI KC5VWAGMNLT6
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- -$34,000
Award facts
- Contract value 0% obligated
- $36,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- 6630 Chemical Analysis Instruments
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Port Chester, NY 10573, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$34,000 | |
| Original award | $70,000 |
About this award
Cytopath Biopsy Lab Inc., operating as Cblpath, received a $36,000 firm fixed-price blanket purchase agreement (BPA) call from Veterans Integrated Service Network (VISN) 6 for ThyroSeq genomic classifier tests. The contract was awarded on October 1, 2024, with a completion date of September 30, 2025, and will be performed at the company's facility in Port Chester, New York. This award is a call order under Cblpath's existing BPA infrastructure with VISN 6, which includes multiple vehicles totaling over $2.6 million in aggregate contract value for thyroid genomic testing services. No small business set-aside was used for this procurement.
Cblpath specializes in molecular diagnostic laboratory services, with a core focus on ThyroSeq technology—an advanced genomic sequencing test that analyzes genetic mutations in thyroid nodules to assess cancer risk and support clinical decision-making for thyroid cancer screening programs. The company has established itself as a primary provider of molecular diagnostic testing services across the Department of Veterans Affairs, holding nine active indefinite delivery contracts and BPAs across multiple VISN regions. This contract supports the VA's ongoing thyroid cancer screening and diagnostic initiatives for the veteran population through delivery of genomic classifier testing services on a per-test basis under firm fixed-price terms.
Quick answers
Who was awarded contract 36C24625N0028?
36C24625N0028 was awarded to Cytopath Biopsy Lab Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C24625N0028 worth?
The government has obligated -$34,000 on 36C24625N0028. Its current value, with exercised options, is $36,000.
Is contract 36C24625N0028 an order under another contract?
Yes. 36C24625N0028 is a BPA call under 36C24624A0017, a blanket purchase agreement.
Was contract 36C24625N0028 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award